20494 ⎘
Medicinal preparations containing organic active ingredients Tetracyclines
COMPOSITIONS INCLUDING CAFFEIC ACID PHENETHYL ESTER
#2COMPOSITIONS OF BIFUNCTIONAL INHIBITORS OF TETRACYCLINE INACTIVATING ENZYMES AND METHODS OF USE THEREOF
#3C7-FLUORO SUBSTITUTED TETRACYCLINE COMPOUNDS
#4Modified Tetracyclines for Treatment of Alcohol Use Disorder, Pain and Other Disorders Involving Potential Inflammatory Processes
#5Methods for Treating a Health Condition with Probiotics
#6USE OF INCYCLINIDE SYNERGIZED WITH COLISTIN IN PREPARATION OF BACTERICIDAL DRUG
#7GENE EXPRESSION-BASED IDENTIFICATION OF EARLY LYME DISEASE
#8ANTIMICROBIAL COMBINATIONS
#9PREVENTATIVE MOUTHWASH CONTAINING DOXYCYCLINE AND METHOD OF PREVENTING COVID INFECTION USING THE PREVENTATIVE MOUTHWASH
#10COMPOSITION FOR ANTIMICROBIAL AND ANTIBIOFILM ACTIVITY CONTAINING HALOGENATED PHENOL DERIVATIVE AS ACTIVE INGREDIENT
#11HEART VALVE PROSTHESES WITH A DRUG ELUTING MECHANISM
#12IL-12 GENE THERAPY AND ANTI-VEGF COMBINATION FOR TREATING CANCER
#13CELLULAR REPROGRAMMING TO REVERSE AGING AND PROMOTE ORGAN AND TISSUE REGENERATION
#14COMPOSITIONS FOR OVERCOMING TETRACYCLINE ANTIBIOTIC RESISTANCE AND METHODS OF USE THEREOF
#15METAL CHELATING COMPOSITIONS AND METHODS FOR CONTROLLING THE GROWTH OR ACTIVITIES OF A LIVING CELL OR ORGANISM
#16CONSUMER PACKAGE FOR BITE TREATMENT CONTAINING A TOPICAL CREAM THAT INCLUDES A TETRACYCLINE OR THIRD GENERATION CEPHALOSPORIN
#17SALTS AND POLYMORPHS OF A TETRACYCLINE COMPOUND
#18PREVENTATIVE MOUTHWASH CONTAINING A SUB-ANTIMICROBIAL ORAL DOSAGE OF DOXYCYCLINE, METHOD OF PREVENTING COVID INFECTION USING THE MOUTHWASH, AND METHOD OF FORMULATING THE MOUTHWASH
#19PARENTERAL COMPOSITIONS OF ZILEUTON AND METHODS OF USE
#20SEMIFLUORINATED ALKANE TETRACYCLINE COMBINATION COMPOSITIONS FOR TREATMENT OF MALAR EDEMA
#21PHARMACEUTICAL COMPOSITIONS AND METHODS OF MAKING ON DEMAND SOLID DOSAGE FORMULATIONS
#22METHODS OF DIAGNOSING OR TREATING LYME DISEASE
#23PHARMACEUTICAL COMPOSITIONS AND METHODS OF MAKING ON DEMAND SOLID DOSAGE FORMULATIONS
#24TETRACYCLINE DERIVATIVES
#25SUBSTITUTED TETRACYCLINE COMPOUNDS FOR TREATMENT OF INFLAMMATORY SKIN DISORDERS
#26CELLULAR REPROGRAMMING TO REVERSE AGING AND PROMOTE ORGAN AND TISSUE REGENERATION
#27C. NOVYI FOR THE TREATMENT OF SOLID TUMORS IN NON-HUMAN ANIMALS
#28ORAL AND INJECTABLE FORMULATIONS OF TETRACYCLINE COMPOUNDS
#29MINOCYCLINE COMPOUNDS FOR BIODEFENSE
#30PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ACNE
#31TRIPLE PHARMACEUTICAL COMPOSITION FOR PROTEINACEOUS INFECTION
#32METHOD OF DELIVERY OF FUSOGENIC ONCOLYTIC VIRUS AND THERAPEUTIC MOLECULES
#33THERAPY AND PREVENTION OF PRION PROTEIN COMPLEX INFECTIONS IN NON-HUMAN ANIMALS
#34METHODS OF TREATING MYCOBACTERIAL INFECTIONS USING TETRACYCLINE COMPOUNDS
#35METHODS FOR TREATING PULMONARY NON-TUBERCULOUS MYCOBACTERIAL INFECTIONS
#36ERAVACYCLINE FOR TREATING CANCER
#37METHODS FOR CONTINUOUS MANUFACTURE OF LIPOSOMAL DRUG PRODUCTS
#38CARDIAC MONITOR DEVICE
#39COMPOSITIONS AND METHODS TO DETECT INFECTIOUS ORGANISMS
#40BONE TARGETED TREATMENT IN OSTEOGENESIS IMPERFECTA
#41Multifunctional Nanoparticles For Prevention and Treatment of Atherosclerosis
#42FORMULATION AND METHOD FOR TREATMENT OF INFECTIONS
#43COMPOSITION FOR IMPROVING DRUG SENSITIVITY OF ANTIBACTERIAL DRUG TO METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA), COMPOSITION FOR TREATING OR PREVENTING MRSA INFECTION, AND COMPOSITION FOR REDUCING VIRULENCE OF MRSA
#44COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASE AND FUSOBACTERIA-CAUSED OR RELATED DISEASES AND CONDITIONS
#459-AMINOMETHYL MINOCYCLINE COMPOUNDS AND USES THEREOF
#46FORMULATION FOR TREATING URINARY SYSTEM DISORDERS
#47NANOTUBE-VESICLE COMPOSITIONS AND USES THEREOF
#48PEPTIDE-BASED BIOMARKERS AND RELATED ASPECTS FOR DISEASE DETECTION
#49TOPICAL TETRACYCLINE COMPOSITIONS
#50APPLICATION OF TETRACYCLINE COMPOUND IN TREATMENT OF TUMOR
#51INHALED ANTIBACTERIAL FORMULATIONS FOR TREATING LUNG INFECTIONS
#52METHODS OF TREATING NON-ARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY
#53USE OF SELF-ASSEMBLED ALKYLSILANE COATINGS FOR DRUG DELIVERY APPLICATIONS
#54SURGICAL SYSTEM AND METHODS OF USE
#55CONTROLLED MUSCLE-SPECIFIC GENE DELIVERY
#56THERAPEUTIC AGENT
#57TOPICAL ANTIBIOTIC
#58DOXYCYCLINE INJECTION FOR SCLEROTHERAPY OF LOWER EYELID FESTOONS AND MALAR EDEMA
#59Methods and Compositions for Inhibiting the Growth and/or proliferation of MYC-Driven Tumor Cells
#60METHODS OF TREATING, AMELIORATING AND/OR PREVENTING FIBRODYSPLASIA OSSIFICANS PROGRESSIVA AND HETEROTOPIC OSSIFICATION, AND KITS FOR THE SAME
#61MULTI-LAYERED POLYMER FILM FOR SUSTAINED RELEASE OF AGENTS
#62PHARMACEUTICAL COMPOSITIONS FOR DEMODEX RELATED BLEPHARITIS AND EYELID CRUSTING
#63MINOCYCLINE COMPOUNDS AND METHODS OF USE THEREOF
#649-AMINOMETHYL MINOCYCLINE COMPOUNDS AND USE THEREOF IN TREATING COMMUNITY-ACQUIRED BACTERIAL PNEUMONIA (CABP)
#65CMT-3 FORMULATIONS AND METHODS OF USING THE SAME
#66ASSOCIATION WITH ANTIBIOTIC ACTIVITY, PHARMACEUTICAL COMPOSITIONS CONTAINING IT AND THEIR USE IN THE TREATMENT OF INFECTIONS
#67ULTRASOUND-RESPONSIVE NANOSCALE DELIVERY PLATFORM FOR USE IN THE TREATMENT OF BIOFILM-ASSOCIATED DISEASES
#68Herbal composition for the treatment of malaria
#69USE OF GENE EDITING TO GENERATE UNIVERSAL TCR RE-DIRECTED T CELLS FOR ADOPTIVE IMMUNOTHERAPY
#70INTRAUTERINE SYSTEMS COMPRISING ANTI-INFECTIVES FOR STEADY-STATE ACCUMULATION TO DISTAL EXTRAUTERINE TISSUE
#71METHOD FOR SUSTAINED DRUG DELIVERY FOR WOUND HEALING USING SILK HYDROGEL AND PRODUCT THEREOF
#72PHARMACEUTICAL FORMULATION
#73Modified Tetracycline for Treatment of Alcohol Use Disorder, Pain and Other Disorders Involving Potential Inflammatory Processes
#74COMPOUNDS AND METHODS TO SENSITIZE CANCER CELLS TO CISPLATIN
#75COMPOSITIONS, GELS AND FOAMS WITH RHEOLOGY MODULATORS AND USES
#76AEROSOL DELIVERY OF EDTA COMPOSITIONS
#77METHODS AND COMPOSITIONS FOR REGENERATING HAIR CELLS AND/OR SUPPORTING CELLS
#78COMPOSITIONS FOR THE IMPROVED TREATMENT OF ACNE AND RELATED DISORDERS
#79COMPOSITIONS AND METHODS AND USES THEREOF
#80METHODS FOR TREATING PULMONARY NON-TUBERCULOUS MYCOBACTERIAL INFECTIONS
#81TETRACYCLINE COMPOSITIONS
#82METHODS FOR TREATING AND PREVENTING C. DIFFICILE INFECTION
#83PHARMACEUTICAL COMPOSITION COMPRISING TIGECYCLINE
#84C7-FLUORO SUBSTITUTED TETRACYCLINE COMPOUNDS
#85LIPOSOME LOADING
#86PERSISTER CONTROL BY LEVERAGING DORMANCY ASSOCIATED REDUCTION OF ANTIBIOTIC EFFLUX
#87COMPOSITIONS AND METHODS OF CLOSTRIDIODIDES DIFFICILE TREATMENT, DECOLONIZATION, AND PREVENTION
#88SELF-EMULSIFYING OIL-IN-WATER MICROEMULSION OR NANOEMULSION, AND EMULSIFYING COMPOSITION
#89TREATMENT OF FRAGILE X SYNDROME
#90SYNERGISTIC TRANSPORT OF LIPOPHILIC AND HYDROPHILIC ACTIVE SUBSTANCES IN NANOPARTICLES
#91CARRIER OR AUXILIARY MATERIAL OF OPHTHALMIC PREPARATION, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#92Combination Therapies with Anti-CD38 Antibodies
#93PHARMACEUTICAL COMPOSITIONS FOR MINOCYCLINE
#94SYSTEM AND METHOD FOR TREATMENT OF BONE
#95METHODS FOR THE TREATMENT AND PREVENTION OF NON-VIRAL TICK-BORNE DISEASES AND SYMPTOMS THEREOF
#96METHODS OF TREATING ABNORMAL CELL GROWTH
#97GASTRIC RESIDENCE SYSTEMS WITH RELEASE RATE-MODULATING FILMS
#98PHARMACEUTICAL COMPOSITIONS
#99METHODS FOR TREATING PULMONARY NON-TUBERCULOUS MYCOBACTERIAL INFECTIONS
#100COMBINATION THERAPY FOR THE TREATMENT OF PAN-KRAS MUTATED CANCERS
#101COMPOSITIONS FOR ORAL CANCER OR AN OROPHARYNGEAL CANCER
#102Compositions and Methods for Treating Spinal Cord Injury and Synaptic Dysfunction
#103Pharmaceutical Compositions And Methods For Treating Neoplasia
#104CELLULAR REPROGRAMMING TO REVERSE AGING AND PROMOTE ORGAN AND TISSUE REGENERATION
#105TRIPLE COMBINATION THERAPIES FOR ANTI-AGING
#106Pharmaceutical formulation
#107TETRACYCLINE DERIVATIVE-INDUCED MITOHORMESIS MEDIATES DISEASE TOLERANCE AGAINST VIRAL INFECTIONS
#108OPHTHALMIC PREPARATION ADMINISTERED BY EYE DROPS AND USED FOR PREVENTING AND TREATING DRY MACULAR DEGENERATION AND RETINAL LIGHT DAMAGE
#109METHODS FOR DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES
#110METHODS OF DIAGNOSING OR TREATING LYME DISEASE
#111GAMETOCYTOCIDAL COMPOUND
#112METHODS OF REDUCING ACNE AND ROSACEA RELAPSE RATE AND SEVERITY
#113Method to Reduce Slosh Energy Absorption and its Damaging Effects Through the Reduction of Inelastic Collisions in an Organism
#114CELLULAR REPROGRAMMING TO REVERSE AGING AND PROMOTE ORGAN AND TISSUE REGENERATION
#115COMPOUNDS AND METHODS TO SENSITIZE CANCER CELLS TO TYROSINE KINASE INHIBITORS
#116COMPOSITIONS, GELS AND FOAMS WITH RHEOLOGY MODULATORS AND USES THEREOF
#117COMPOSITIONS, GELS AND FOAMS WITH RHEOLOGY MODULATORS AND USES THEREOF
#118SURGICAL SYSTEM AND METHODS OF USE
#119METHODS AND MATERIALS FOR IDENTIFYING AND TREATING MEMBRANOUS NEPHROPATHY
#120COMPOSITIONS AND METHODS FOR THE TREATMENT AND PROPHYLAXIS OF SURGICAL SITE INFECTIONS
#121MINOCYCLINE COMPOUNDS FOR BIODEFENSE
#122Methods of treating non-arteritic anterior ischemic optic neuropathy
#123Multi-layered polymer film for sustained release of agents
#124MINOCYCLINE COMPOUNDS AND METHODS OF USE THEREOF
#125TRANSDERMAL PENETRANT FORMULATIONS FOR ADMINISTRATION OF MEDICAMENTS
#126Patient Treatment Via Teratogenic Pharmaceutical Compounds
#127COMBINATION OF ZIDOVUDINE WITH A TETRACYCLINE ANTIBIOTIC
#128Tetracycline compositions
#129Multifunctional Nanoparticles For Prevention And Treatment Of Atherosclerosis
#130SILICON PARTICLES FOR DRUG DELIVERY
#131METHOD FOR SUPPRESSING CANCER METASTASIS THROUGH ALTERATION OF ADHESION DEPENDENCE OF CANCER CELLS
#132NOVEL METHOD
#133Treatment of rhinosinusitis with P-glycoprotein inhibitors
#134SULFONAMIDES AND THEIR USE FOR TREATMENT OF HELMINTHIC INFECTIONS AND DISEASES
#135COMBINATION THERAPY FOR TREATMENT OF CONDITIONS ASSOCIATED WITH AGING
#136CATIONIC AMPHIPHILIC POLYMERS FOR CODELIVERY OF HYDROPHOBIC AGENTS AND NUCLEIC ACIDS
#137MINOCYCLINE COMPOUNDS AND METHODS OF USE THEREOF
#138TRANSDERMAL PENETRANT FORMULATIONS FOR ADMINISTRATION OF MEDICAMENTS
#139Implantable cellular and biotherapeutic agent delivery canister
#140METHODS AND COMPOSITIONS FOR TREATMENT OF COVID-19
#141METHOD OF TREATING A PERSON AFFLICTED WITH A RESPIRATORY CONDITION AND PHARMACEUTICAL FORMULATION INCLUDING DAPSONE
#142DRUGS, THERAPEUTIC COMBINATIONS AND METHODS FOR PREVENTING VIRAL AND MICROBIAL INFECTIONS AND THEIR SEQUELAE
#143THERAPEUTIC COMBINATIONS INCLUDING INHIBITORS OF THE P2X4 RECEPTOR FOR TREATING AND PREVENTING PROLIFERATIVE DISORDERS
#144COMPOSITIONS AND METHODS FOR TREATING, AMELIORATING AND PREVENTING H. PYLORI INFECTIONS
#145COMPOSITION AND USE
#146PHARMACEUTICAL COMPOSITION COMPRISING SULBACTAM AND AVIBACTAM, AND APPLICATION THEREOF
#147Methods for Treating a Health Condition with Probiotics
#148ANTIMICROBIAL CATHETERS
#149ASSAYS FOR DETECTION OF ACUTE LYME DISEASE
#150TETRACYCLINE DERIVATIVES FOR TREATING NEURODEGENERATIVE OR NEUROINFLAMMATORY DISEASES
#151COMPOSITION COMPRISING NAPHTHOQUINONE-BASED COMPOUND AS ACTIVE INGREDIENT, FOR PREVENTING OR AMELIORATING FATIGUE, CACHEXIA, PAIN, COGNITIVE DECLINE AND HEMATOPOIETIC STEM CELL REDUCTION WHICH ARE SIDE EFFECTS RELATED TO ANTICANCER DRUG TREATMENT
#152CANCER THERAPEUTIC
#153SOLVENT DELIVERY SYSTEM FOR TOPICAL DELIVERY OF ACTIVE AGENTS
#154Spirolactone compounds
#155COMPOSITIONS AND METHODS AND USES THEREOF
#156CELLULAR REPROGRAMMING TO REVERSE AGING AND PROMOTE ORGAN AND TISSUE REGENERATION
#157Methods of Treating Cystic Fibrosis
#158Methods for treating pulmonary non-tuberculous mycobacterial infections
#159MICROBIAL STRAINS AND ANTIBIOTICS
#160NUCLEIC ACID-BINDING PHOTOPROBES AND USES THEREOF
#161PLATELET MEMBRANE COATED NANOPARTICLES AND USES THEREOF
#162Short Proline Rich Lipopeptide Potentiates Minocycline and Rifampicin Against Multidrug- and Extensively Drug-Resistant Pseudomonas Aeruginosa
#163MEANS AND METHODS FOR TREATING BACTERIAL INFECTIONS
#164Methods of Making and Using Nanoparticles for Treatment of Bacterial Biofilm
#165COMPOSITIONS AND METHODS OF USE OF GENETICALLY MODIFIED IMMUNE CELLS EXPRESSING MATRIX METALLOPEPTIDASE
#166Antibacterial chemical compound, its manufacturing method and its use thereof
#167COMPOSITIONS FOR THE IMPROVED TREATMENT OF ACNE AND RELATED DISORDERS
#168SUSTAINED RELEASE CANCER THERAPEUTICS FORMULATIONS
#169Therapeutic bacteriophage compositions for treating infection
#170TREATMENT OF FRAGILE X SYNDROME
#171PHARMACEUTICAL FORMULATION
#172Topical antibiotic
#173METHODS AND COMPOSITIONS FOR TREATING DISEASES ASSOCIATED WITH SENESCENCE
#174RECOMBINANT ADENOVIRUS GENOME HAVING A SYNTHETIC TRANSCRIPTIONAL UNIT AND TWO STEP TRANSCRIPTIONAL REGULATION AND AMPLIFICATION
#175COMPOUNDS FOR USE IN THE TREATMENT OF VIRAL INFECTIONS BY RESPIRATORY SYNDROME-RELATED CORONAVIRUS
#176Methods for continuous manufacture of liposomal drug products
#177INHIBITION OF SLC TRANSPORTER ACTIVITY OR EXPRESSION TO ATTENUATE ANTHRACYCLINE-INDUCED CARDIOTOXICITY
#178PHARMACEUTICAL COMPOSITIONS FOR RELIEF OF COVID-19 SYMPTOMS AND METHODS OF PRODUCING AND USING THEM
#179Hybrid polyvinyl alcohol/ linseed dual crosslinked nanocomposite hydrogel loaded with doxycycline for the production of acne patches
#180THERAPEUTIC METHODS FOR PREVENTING TUMOR METASTASIS AND TUMOR RECURRENCE
#181Use of self-assembled alkylsilane coatings for drug delivery applications
#182COMPOSITIONS AND METHODS FOR TREATING VIRUSES
#183DRUG-RELEASING POLYMER COMPOSITION AND DEVICE
#184COLLAGEN-BASED DEVICE HAVING ANTIFUNGAL PROPERTIES
#185METHOD OF TREATING GENE THERAPY ASSOCIATED TOXICITY WITH ANTIBIOTICS
#186BISMUTH-THIOLS AS ANTISEPTICS FOR EPITHELIAL TISSUES, ACUTE AND CHRONIC WOUNDS, BACTERIAL BIOFILMS AND OTHER INDICATIONS
#187Methods for treating inflammatory skin conditions
#188PHARMACEUTICAL COMPOSITIONS COMPRISING AMPHIPHILIC PEPTIDES AND METHODS OF USE THEREOF
#189Modified tetracycline for treatment of alcohol use disorder, pain and other disorders involving potential inflammatory processes
#190STABLE TOPICAL TETRACYCLINE COMPOSITIONS
#191C7-FLUORO SUBSTITUTED TETRACYCLINE COMPOUNDS
#192PHARMACEUTICAL FORMULATION
#193METHODS OF TREATING ILLNESSES CAUSED BY CORONAVIRUS, SWINE FLU AND AVIAN FLU
#194COMBINATION OF ANETHOLE TRITHIONE OR ITS DERIVATIVE, 4-OH-ANETHOLE TRITHIONE, WITH DOXYCYCLINE OR MINOCYCLINE FOR THE USE THEREOF IN THE TREATMENT OF PARKINSON'S DISEASE
#195COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS AND POTENTIATION OF ANTIBIOTICS
#196MINOCYCLINE COMPOUNDS FOR BIODEFENSE
#197DIROFILARIA VOLATILE ORGANIC COMPOUND SIGNATURES AND USES THEREOF
#198USE OF DOXYCYCLINE, RESVERATROL, IVERMECTIN, AND RELATED CHEMICALLY MODIFIED COMPOUNDS TO TREAT OR PREVENT VIRAL INFECTIONS
#199AUTOANTIGENIC PEPTIDES (CALVICIFIV), PRESENTED BY TOLEROGENIC DENTRITIC CELLS, USEFUL FOR THE PERSONALIZED TREATMENT OF RHEUMATOID ARTHRITIS
#200SURGICAL SYSTEM AND METHODS OF USE
#201PERIODONTAL MICROPATCH AND USES THEREOF
#202METHODS OF TREATING TUMORS
#203Implantable cellular and biotherapeutic agent delivery canister
#204Anti-malarial agents
#205Method of treatment of topical dermatologic acne using a cream composition and method of manufacture
#206Cellular reprogramming to reverse aging and promote organ and tissue regeneration
#207METHODS TO ENHANCE BIOAVAVAILABILITY OF ORGANIC SMALL MOLECULES AND DEPOSITED FILMS MADE THEREFROM
#208RESIDENCE STRUCTURES AND RELATED METHODS
#209Methods for treating pulmonary non-tuberculous mycobacterial infections
#210NAD(H) NANOPARTICLES AND METHODS OF USE
#211Topical Compositions For Treating Skin Ailments
#212TETRACYCLINE COMPOUNDS AND METHODS OF TREATMENT
#213Method of treating a person afflicted with COVID-19 and pharmaceutical formulation including dapsone
#214KIT, COMPOSITION, AND COMBINATION THERAPY FOR FRAGILE X SYNDROME
#215NEW GENERATION REGULATABLE FUSOGENIC ONCOLYTIC HERPES SIMPLEX VIRUS TYPE 1 VIRUS AND METHODS OF USE
#216Methods and compositions for treatment of COVID-19
#217TOPICAL MINOCYCLINE OINTMENT FOR SUPPRESSION OF ALLERGIC SKIN RESPONSES
#218CODON OPTIMIZED NEW GENERATION REGULATABLE FUSOGENIC ONCOLYTIC HERPES SIMPLEX VIRUS TYPE 1 VIRUS AND METHODS OF USE
#219HEMOSTATIC DEVICES AND METHODS OF USE
#220USE OF MEMBRANE INHIBITORS TO ENHANCE VACCINE DEVELOPMENT AGAINST ENVELOPED VIRUSES
#221Derivatives of antibiotics
#222Methods for treating pulmonary non-tuberculous mycobacterial infections
#223Compositions and methods for the treatment and prophylaxis of surgical site infections
#224COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS FOR PREVENTION AND/OR TREATMENT OF DYSBIOSIS AND ANTIBACTERIAL ANTIDOTES FOR MICROBIOME-PROTECTION
#225ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITION COMPRISING PROBIOTICS AND ANTIBIOTICS, AND METHOD USING SAME
#226USE OF STARCH NANOPARTICLES LOADED WITH ACTIVE MOLECULES FOR AQUACULTURE
#227C. NOVYI FOR THE TREATMENT OF SOLID TUMORS IN HUMANS
#228Compositions and methods of clostridiodides difficile treatment, decolonization, and prevention
#229Tissue engineered synthetic support structure
#230Multifunctional Nanoparticles For Prevention And Treatment Of Atherosclerosis
#231METHODS AND COMPOSITIONS FOR TREATING PAIN AND OTHER EPH RECEPTOR-ASSOCIATED CONDITIONS
#232Targeted Nanoparticle For The Treatment Of Traumatic Brain Injury And Other CNS Diseases
#233SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING (1R, 5S)-1-(NAPHTHALEN-2-YL)-3-AZABICYCLO[3.1.0]HEXANE
#234TREATMENT OF TRAUMATIC ENCEPHALOPATHY BY FIBROBLASTS AND THERAPEUTIC ADJUVANTS
#235COMPOSITIONS AND METHODS FOR TREATING SPINAL CORD INJURY AND SYNAPTIC DYSFUNCTION
#236SMALL-MOLECULAR ADJUVANTS AND IMPLEMENTATIONS THEREOF
#237METHODS OF TREATMENT AND/OR PREVENTION OF DISORDERS AND SYMPTOMS RELATED TO BKCA AND/OR SK CHANNELOPHATHIES
#238SULFUR (VI) FLUORIDE COMPOUNDS AND METHODS FOR THE PREPARATION THEREOF
#239Nano composite material aiming at acidic sealing zone in osteoclasts and preparation method thereof
#240Triple pharmaceutical composition for proteinaceous infection
#241Composition and Method of Preparation for Lipid Formulations Comprising Charged Lipids
#242POLYMER AND COMPOSITION FROM RENEWABLE SOURCE
#243TOPICAL JAK INHIBITOR COMBINATION COMPOSITIONS FOR TREATMENT OF INFLAMMATORY SKIN CONDITIONS
#244TREATMENT APPROACH BY TARGETED DELIVERY OF BIOACTIVE MOLECULES
#245DNA-AFFIBODY-DRUG NANOPARTICLES FOR INHIBITING THE METASTASIS OF CANCER CELLS OVEREXPRESSING HER2
#246ANTI-INFECTION EFFECTS OF HNRNPA2B1 AND USE THEREOF
#247COMBINATION FOR THE TREATMENT OF INFECTIONS CAUSED BY MYCOPLASMA GENITALIUM
#248CARBOCYANINE COMPOUNDS FOR TARGETING MITOCHONDRIA AND ERADICATING CANCER STEM CELLS
#249Treatment methods for medical and dental implants, periodontal diseases and medical procedures
#250PHARMACEUTICAL COMPOSITION AND KIT CONTAINING NOVEL PENAM DERIVATIVE OR SALT THEREOF AND ONE OR MORE COMPOUNDS SELECTED FROM beta-LACTAMASE INHIBITORY COMPOUND AND ANTIBACTERIAL COMPOUND OR SALTS THEREOF
#251Improved administration of glycylcyclines by inhalation
#252METHOD AND COMBINATION FOR TREATING VIRAL INFECTION AND LONG HAULER SYNDROME
#253ADC FOR A TREATMENT CONCOMITANT WITH OR SUBSEQUENT TO DOCETAXEL
#254COMPOSITIONS AND METHODS FOR IMPROVING TREATMENT OUTCOMES FOR PATIENTS HAVING HEMATOLOGICAL MALIGNANCIES USING AN EXPANDED STEM CELL PRODUCT
#255Surgical system and methods of use
#256MEDICAL DEVICE AND METHOD FOR PRODUCING MEDICAL DEVICE
#257Surgical system and methods of use
#258ALKYL-TPP COMPOUNDS FOR MITOCHONDRIA TARGETING AND ANTI-CANCER TREATMENTS
#259UVEAL MELANOMA TREATMENT
#260Dirofilaria volatile organic compound signatures and uses thereof
#261Therapeutics and methods for predicting and overcoming endocrine resistance in breast cancer
#262METHODS FOR MODULATING CHEMOTHERAPEUTIC CYTOTOXICITY
#263COMPOSITIONS AND METHODS FOR TREATING AGE-RELATED MACULAR DEGENERATION
#264Parasite therapy
#265Doxorubicin Containing Nanoplexes and Uses Thereof
#266METHODS OF TREATING CHARCOT-MARIE-TOOTH DISEASE
#267COMBINATION OF MINOCYCLINE AND BENZOYL PEROXIDE AND METHOD OF USE THEREOF
#268Small molecule inhibitors of bacterial efflux pumps and methods of using same
#269TREATMENT OF ROSACEA WITH TOPICAL COMBINATION COMPOSITIONS
#270COMPOSITIONS AND METHODS FOR SUSTAINED DRUG RELEASE FROM AN INJECTABLE HYDROGEL
#271METHODS OF TREATING RHEUMATOID ARTHRITIS AND FOR PREDICTING THE RESPONSE TO METHOTREXATE
#272CANNABINOID COMPOSITIONS AND USE THEREOF
#273TARGETS AND METHODS FOR TREATING EPSTEIN-BARR VIRUS MEDIATED NEURODEGENERATION
#274Materials and Methods for Enhanced Treatment and Prevention of Biofilms
#275Implantable cellular and biotherapeutic agent delivery canister
#276Targeted In Vivo Genome Modification
#277MINOCYCLINE FOR THE TREATMENT OF PITT-HOPKINS SYNDROME
#278COMPOSITIONS AND METHODS FOR TREATMENT OF A CORONAVIRUS DISEASE (COVID-19) INFECTION
#279Pharmaceutical compositions for demodex related blepharitis and eyelid crusting
#280Periodontic treatment and method
#281COMPOSITIONS AND METHODS FOR TREATING AN INFECTION
#282Vitamin c and doxycycline: a synthetic lethal combination therapy for eradicating cancer stem cells (CSCS)
#283THERAPY AND PREVENTION OF PRION PROTEIN COMPLEX INFECTIONS IN NON-HUMAN ANIMALS
#284Methods of treating amyloid-beta peptide diseases
#285TOPICAL MINOCYCLINE FOAMABLE COMPOSITIONS
#286Use of IGFBP7 for treating malaria
#287TARGETING HYPOXIC CANCER STEM CELLS (CSCS) WITH DOXYCYCLINE: IMPLICATIONS FOR IMPROVING ANTI-ANGIOGENIC THERAPY
#288USE OF LEVOCETIRIZINE AND MONTELUKAST IN THE TREATMENT OF TRAUMATIC INJURY
#289METHOD OF TREATING OR AMELIORATING SKIN CONDITIONS WITH A MAGNETIC DIPOLE STABILIZED SOLUTION
#290COMPOSITIONS AND METHODS FOR TREATING CARDIAC INJURY
#291COMPOSITIONS AND METHODS FOR TREATING OCULAR CONDITIONS
#292Multi-layered polymer film for sustained release of agents
#293Upregulation of therapeutic T regulatory cells and suppression of suicidal ideations in response to inflammation by administration of nutraceutical compositions alone or combined with minocycline
#294METHODS AND COMPOSITIONS FOR TREATING ROSACEA
#295Topical doxycycline hydrogel with improved long-term stability
#296DETECTION OF DNA SEQUENCES AS RISK FACTORS FOR HIV INFECTION
#297TRIPLE COMBINATION THERAPIES FOR TARGETING MITOCHONDRIA AND KILLING CANCER STEM CELLS
#298Modified tetracycline for treatment of alcohol use disorder, pain and other disorders involving potential inflammatory processes
#299MODIFIED RELEASE DOXYCYCLINE COMPOSITION
#300System and method for treatment of bone